{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021548","form_type":"8-K","ticker":"DSS","cik":"0000771999","company_name":"DSS, INC.","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.348451+00:00","generated_at":"2026-05-17T23:20:44.385885+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DSS converts $12M Impact Biomedical debt into 31.9M shares of Impact common stock","bullets":["DSS settled all outstanding debt owed by Impact Biomedical under a $12M original note and amendments.","In exchange, DSS received 31,939,778 freely tradeable shares of Impact's common stock.","Transaction closed on July 21, 2025; issuance of shares constituted full satisfaction of amounts owed to DSS."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021548","json":"https://secwatch.observer/filing/0001641172-25-021548.json","markdown":"https://secwatch.observer/filing/0001641172-25-021548.md","text":"https://secwatch.observer/filing/0001641172-25-021548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/771999/000164117225021548/0001641172-25-021548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/771999/000164117225021548/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:20:44.385885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}